First Eagle Investment Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
First Eagle Investment Management's MRVI Position: Q3 2026 in Review
First Eagle Investment Management reduced its Maravai LifeSciences (MRVI) stake by 11% in Q3 2026, selling an estimated $2.69M and leaving 3,282,326 shares worth $25.1M. The position accounts for 0.04% of the portfolio, ranked #97.
First Eagle Investment Management first reported a position in MRVI in Q3 2025 and has held it in 5 quarters since. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- First Eagle Investment Management held 3,282,326 shares of Maravai LifeSciences worth $25.1M as of Q3 2026.
- First Eagle Investment Management sold 388,961 Maravai LifeSciences shares in Q3 2026, an estimated $2.69M.
- Maravai LifeSciences made up 0.04% of First Eagle Investment Management's portfolio in Q3 2026, its #97 holding.
- First Eagle Investment Management first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 5 quarters since.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on First Eagle Investment Management's 13F filing for Q3 2026, filed 10 Nov 2026.